Abbott Vascular’s Ferolyn Powell talks about the company’s MitraClip technology, which is used to treat a common heart valve condition called mitral regurgitation.
The MitraClip device is designed to reduce significant mitral regurgitation by clipping together the leaflets of the mitral valve, one of the four valves of the heart.
Powell, vice president and general manager of Abbott’s structural heart division, was interviewed at the Cleveland Clinic Medical Innovation Summit, which focused on cardiovascular disease.
Advertisement
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.
By Brandon Glenn MedCity News
Brandon Glenn is the Ohio bureau chief for MedCity News.More posts by Author
0 comments
- Get Livefyre
- FAQ
Newest | Oldest
